Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Genetic toxicity in vivo

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Additional information

Glufosinate ammonium was tested in a wide range of in vitro tests including an Ames test on four strains of Salmonella typhimurium (TA98, TA100, TA1335 and TA1537) and one Escherichia coli (WP2 uvrA), a gene conversion DNA repair test at the "Ade 2" and "Trp 5" loci on different chromosomes of the Saccharomyces cervisiae cell, a forward gene mutation assay in 5 different genes of the Schizosaccharomyces pombe cell, an in vitro chromosome aberration test in cultured human lymphocytes, an HPRT test in Chinese hamster cell line V79 and a rat primary hepatocyte unscheduled DNA synthesis assay and an in vivo micronucleus test in NMRI mice. In all these tests, glufosinate ammonium did not induce any mutagenic effects in presence or absence of metabolic activation.

Justification for classification or non-classification

In all genotoxicity tests available, glufosinate ammonium did not induce any mutagenic effects in presence or absence of metabolic activation. Therefore, classification according to Regulation (EC) 1272/2008 is not warranted.